RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of Health Services Director, a Purchase Order with Roche Diagnostics Corporation, in an amount not to exceed $1,500,000 for reagents used in the Public Health (PH) Laboratory, for the period from July 1, 2019 through June 30, 2022.
FISCAL IMPACT:
100% funding is included in the Hospital Enterprise Fund I budget.
BACKGROUND:
Roche Diagnostic Corporation has been used by the Health Services Department for over twenty (20) years. Roche provides the reagents required for use with the testing instrument in our PH Laboratory. The reagents are necessary for specimens to be tested for viruses & bacteria such as Hepatitis B & C and HIV. Additionally, the Public Health Laboratory is required to use these specific reagents to keep us in compliance with our Instrument Maintenance Agreement.
|